Klinik Kronborg ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.0% 10.3% 13.0% 7.5% 3.8%  
Credit score (0-100)  22 22 17 31 51  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -5.4 -5.4 0.0 629 731  
EBITDA  -5.4 -5.4 0.0 564 664  
EBIT  -5.4 -5.4 0.0 564 657  
Pre-tax profit (PTP)  44.1 54.5 54.3 657.6 682.3  
Net earnings  44.1 54.5 54.3 623.7 539.9  
Pre-tax profit without non-rec. items  44.1 54.5 54.3 658 682  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 31.3  
Shareholders equity total  -134 -79.9 -5.1 712 1,308  
Interest-bearing liabilities  751 771 715 0.0 0.0  
Balance sheet total (assets)  616 691 710 1,501 1,490  

Net Debt  751 771 5.1 -1,423 -1,365  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -5.4 -5.4 0.0 629 731  
Gross profit growth  -39.4% 0.0% 0.0% 0.0% 16.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  616 691 710 1,501 1,490  
Balance sheet change%  11.6% 12.2% 2.7% 111.6% -0.8%  
Added value  -5.4 -5.4 0.0 564.0 663.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 -303 272  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 0.0 1.0 2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 0.0% 89.7% 90.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.0% 9.1% 9.2% 59.4% 47.7%  
ROI %  8.0% 9.1% 9.2% 92.2% 70.6%  
ROE %  7.5% 8.3% 7.8% 87.7% 53.4%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -17.9% -10.4% -0.7% 47.4% 87.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -13,941.5% -14,321.7% 0.0% -252.3% -205.7%  
Gearing %  -558.7% -965.2% -13,950.6% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  2.0% 2.0% 1.9% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.0 1.0 1.8 7.5  
Current Ratio  0.0 0.0 1.0 1.8 7.6  
Cash and cash equivalent  0.0 0.0 709.6 1,422.9 1,365.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -750.6 -771.1 -714.7 -254.7 198.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0